⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TRDA News
Entrada Therapeutics, Inc. Common Stock
Bronstein, Gewirtz & Grossman, LLC Encourages Entrada Therapeutics, Inc. (TRDA) Investors to Inquire about Securities Investigation
accessnewswire.com
TRDA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA
accessnewswire.com
TRDA
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Entrada Therapeutics, Inc. (TRDA) And Encourages Investors to Reach Out
accessnewswire.com
TRDA
Entrada Therapeutics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
TRDA
Form 8-K
sec.gov
TRDA
Entrada Therapeutics Reports First Quarter 2026 Financial Results
globenewswire.com
TRDA
Entrada Therapeutics Announces Positive Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study
globenewswire.com
TRDA
Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026
globenewswire.com
TRDA
Terradepth’s Absolute Ocean Cleared for Immediate U.S. Navy Use via NIWC Atlantic RCC Hopper
businesswire.com
TRDA
Entrada Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
TRDA